通过皮肤进行的机械循环支持急性右心力衰竭:一种实际的方法
Mario Gramegna1, Christophe Vandenbriele2,3, Guido Tavazzi4,5
1Cardiac and Cardiac Surgery Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ESC heart failure
|April 21, 2025
概括
穿皮右心室辅助器件 (pRVADs) 为急性右心力衰竭提供了关键的血液动力支持,这种急性右心力衰竭对标准治疗不耐药. 本综述详细介绍了它们的使用,患者选择和管理策略,以改善结果.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 医疗器械 医疗器械
背景情况:
- 急性右心力衰竭 (RHF) 是一种严重的疾病,死亡率高.
- 对于严重的RHF,传统的治疗方法往往不足.
- 穿皮右心室辅助器件 (pRVADs) 正成为一种关键的治疗方法.
研究的目的:
- 审查pRVADs在治疗急性RHF中的作用.
- 概述患者选择,设备实施和断奶策略.
- 讨论pRVAD治疗中的挑战,并发症和未来方向.
主要方法:
- 对 pRVADs 的当代证据和专家共识的审查.
- 使用肺动脉导管和心声回声仪进行血液动力学评估的分析.
- 讨论临床情景,并发症和管理方案.
主要成果:
- pRVAD在各种RHF病因中提供有针对性的血液动力学支持.
- 精心评估和监测对于成功实施prvad至关重要.
- 有效的断奶策略侧重于RV恢复和血液动力学稳定.
结论:
- 对于耐火性急性RHF,prvad是一种至关重要的选择.
- 为了获得最佳的结果,需要采用多学科的方法和进一步的创新.
- 这一综述为pRVAD治疗中的临床决策提供了一个框架.
相关概念视频
Cardiac Catheterization II: Right Heart Catheterization
2.2K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
2.2K
Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753


